Ali Amiri

Ali Amiri

Auto-generated profile, based on publicly available information

Ali Amiri

Division of Urology, Department of Surgery, Princess Margaret Cancer Centre, University Health Network, University of Toronto, Toronto, Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2021 in Andrology
Verified
Journal Article
Open access
PDF file
AAAli Amiri
Ali Amiri
MCMichal Chovanec
Michal Chovanec
VOViktor Oliva
Viktor Oliva
MSMilan Sedliak
Milan Sedliak
MMMichal Mego
Michal Mego
BUBarbara Ukropcová
Barbara Ukropcová
Background: Testicular germ cell tumors (TGCTs) represent ∼95% of testicular malignancies and are the most common type of malignancy in young male adults. While the incidence of TGCTs has increased during the last decades, the advances in treatment, namely introducing cisplatin into the chemotherapy regimen, have made TGCTs highly curable with the 10‐year survival rate exceeding 95%. However, in parallel with increased cure rates, survivors may experience acute and late adverse effects of treatment, which increase morbidity, reduce the quality of life, and can be potentially life‐threatening. Chemotherapy‐related toxicities include cardiovascular and metabolic diseases, secondary cancer, avascular necrosis, cognitive impairment, cancer‐related fatigue, poor mental health‐related quality of life, nephrotoxicity, hypogonadism, neurotoxicity, pulmonary toxicity, anxiety, and depression. These treatment‐related adverse effects have emerged as important survivorship dilemmas in TGCT cancer survivors. Recently, regular physical exercise has increasingly attracted research and clinical attention as an adjunct therapy for cancer patients.Purpose: Herein, we review the most common chemotherapy‐related adverse effects in TGCT survivors and clinical relevance of exercise and increased cardio‐respiratory fitness in modulating chemotherapy‐related toxicity and quality of life in this population.Results and conclusion: Exercise has positive effects on a spectrum of physical and psychosocial outcomes during and after cancer treatment, and current guidelines on exercise prescription in chronic diseases define the recommended dose (volume and intensity) of regular exercise for cancer survivors, highlighting regular, sufficiently intensive physical activity as an essential part of patients’ care.

1 September 2019
Verified
Journal Article
Open access
PDF file
ARAlireza Rajaei
Alireza Rajaei
AAAli Amiri
Ali Amiri
FFFaraneh Farsad
Faraneh Farsad
PDPooneh Dehghan
Pooneh Dehghan
Background: Trabecular bone score (TBS) measures the underlying quality of bone texture using dual-energy X-ray absorptiometry (DXA) images. The present study aimed to investigate the correlation between lumbar spine bone mineral density (BMD) and TBS, and subsequently determine whether the association varies with the body mass index (BMI). Methods: Data from 548 patients were collected and categorized into three groups according to the relationship between BMD and age. BMD of the lumbar spine (LS) using DXA and TBS from DXA images were measured. Pearson’s correlation coefficient (SPSS software, version 24.0) was used to investigate the association between LS-BMD and TBS, as well as the effect of BMI and age on these parameters. PResults: The total mean TBS was 1.31±0.12. LS-BMD and TBS values significantly decreased with age in both sexes. A statistically significant correlation was found between TBS and LS-BMD (r=0.601). An increase in BMI was associated with a higher LS-BMD score and a lower TBS level. The correlation coefficient between LS-BMD and TBS reduced as the BMI increased. By comparing TBS with BMD, the majority of the patients with osteopenia and osteoporosis had fully degraded and partially degraded TBS, respectively.Conclusion: TBS was positively correlated with LS-BMD and decreased with age. Moreover, the extent of the correlation varied with respect to BMI.

12 April 2025 in JNCI: Journal of the National Cancer Institute
Verified
Journal Article
Closed access
AMAhmad Mousa
Ahmad Mousa
AAAli Amiri
Ali Amiri
SKSanchit Kaushal
Sanchit Kaushal
EWEmma Wilson
Emma Wilson
VJViranda H Jayalath
Viranda H Jayalath
RHRobert J Hamilton
Robert J Hamilton
Background: Testicular germ cell tumors (TGCTs) are the most common malignancy in men 15-35 years of age. Management options for men with TGCTs include surgery, radiation, and/or chemotherapy. Given TGCTs’ excellent survival, most patients live long enough to experience delayed treatment toxicities, warranting careful consideration of therapeutic decisions. An important outcome of interest is the development of secondary malignant neoplasms (SMNs). Methods: A systematic literature search was conducted through a combination of database searches (Medline, EMBASE, and Cochrane library) and manual review. Studies evaluating the incidence of SMNs in patients following treatment for TGCTs were identified. Our primary outcome was the diagnosis of any non-germ cell SMN following treatment, compared with the general population. Meta-analyses were performed using random-effects models, with outcomes reported as standardized incidence ratios (SIRs). Strength of evidence was evaluated using the GRADE framework. Results: Twenty-one studies including 88 863 patients with 5180 SMNs were included. Median follow-up was 12.5 years. The incidence of non-germ cell SMNs following definitive treatment of TGCTs varied by treatment modality. Surgery alone was not associated with an increased risk (SIR = 0.99, 95% confidence interval [CI] = 0.84 to 1.17); radiation (SIR = 1.66, 95% CI = 1.43 to 1.93), chemotherapy (SIR = 1.65, 95% CI = 1.39 to 1.96), and combined chemotherapy and radiation (SIR = 2.73, 95% CI = 2.23 to 3.33) were associated with a moderate to large increase in risk. There was low to moderate certainty in quality of evidence by GRADE framework. Conclusions: Chemotherapy, radiation, and their combination are associated with an increased risk of non-germ cell SMNs after the treatment of TGCTs.

26 August 2023 in Supportive Care in Cancer
Verified
Journal Article
Open access
PDF file
AAAli Amiri
Ali Amiri
PKPatrik Krumpolec
Patrik Krumpolec
Michal MegoMichal Mego
Michal Mego
BUBarbara Ukropcová
Barbara Ukropcová
MCMichal Chovanec
Michal Chovanec
JUJozef Ukropec
Jozef Ukropec
Purposes: Physical activity (PA) may mitigate late cardiometabolic toxicity of cisplatin-based chemotherapy in testicular germ cell tumor (TGCT) long-term survivors. In this cross-sectional study, we evaluated the effects of habitual PA on metabolic syndrome (MetS) prevalence, and on the markers of cardiometabolic health and chronic inflammation in a population of long-term TGCT survivors. Methods: MetS prevalence was evaluated, and habitual PA was assessed using Baecke’s habitual PA questionnaire in TGCT survivors (n=195, age=41.1±8.1years, 11.7±5.2years post-therapy) and healthy male controls (n=41, age=38.2±8.8years). Participants were stratified into low- and high-PA groups based on median values. Differences were examined between low- and high-PA groups (in the entire sample, TGCT survivor sub-samples differing in disease stage, and healthy controls), and between TGCT survivors and controls. Next, TGCT survivors were stratified into age- and BMI-matched sub-groups based on post-treatment time (5–15/15/30years) and number of chemotherapy cycles (≤3/>3), allowing us to detect age- and BMI-independent effects of habitual PA on cardiometabolic health in the given TGCT survivor sub-populations. A correlation matrix of habitual PA and sport activity with cardiometabolic and pro-inflammatory markers was generated. Results: TGCT survivors had higher MetS prevalence than controls. Patients with high habitual PA had lower waist circumference and Systemic Inflammation Index. Habitual PA scores correlated positively with HDL-cholesterol and negatively with waist circumference and atherogenic risk. Furthermore, cardiometabolic benefits of habitual PA were more pronounced in patients with disease stages 1 and 2. Effects of habitual PA on patients sub-populations stratified by chemotherapy dose and post-treatment time clearly showed that higher levels of habitual PA were associated with lower numbers of MetS components, except for patients who received more than 3 chemotherapy cycles and were examined more than15 years post-therapy. Conclusions: Higher levels of habitual PA effectively mitigated cardiometabolic toxicity in TGCT survivors. Patients with higher cumulative doses of chemotherapy may need structured exercise interventions involving higher-intensity physical activity to achieve significant improvements in cardiometabolic health.

7 April 2025 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Closed access
PDF file
AAAli Amiri
Ali Amiri
WXWei Xu
Wei Xu
QZQihuang Zhang
Qihuang Zhang
JJJae H. Jeong
Jae H. Jeong
SFStephen J. Freedland
Stephen J. Freedland
RHRobert J. Hamilton
Robert J. Hamilton